PE/Cyanine7 anti-mouse CD3 Antibody
- 产品名称：
- PE/Cyanine7 anti-mouse CD3 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 100219
- 产品应用：
- 100219
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- γδTCR-positive T-T hybridoma D1
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.
- Additional Product Notes
- BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
- Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
- Product Citations
-
- Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
- Ho J, et al. 2016. PLoS Biol. 14:e2000117. PubMed
- Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
- Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
- Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
- Schneider C, et al. 2018. Cell. 174:271. PubMed
- Page N, et al. 2018. Immunity. 48:937. PubMed
- Vacca M, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01462. PubMed
- Xiao C, et al. 2021. Front Pharmacol. 12:721273. PubMed
- Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
- d'Errico P, et al. 2021. Nat Neurosci. Online ahead of print. PubMed
- Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
- Ercoli G, et al. 2021. Front Immunol. 11:611661. PubMed
- Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
- Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
- Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
- Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed
- Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
- Chen S, et al. 2022. Cancer Discov. :. PubMed
- Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
- De Vlaeminck Y, et al. 2020. Cancers (Basel). 12:. PubMed
- Liang Y, et al. 2020. J Immunol. 204:2984. PubMed
- Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
- Feizi N, et al. 2021. Cell Death Dis. 12:1026. PubMed
- Patnode M, et al. 2013. J Biol Chem. 288:26533. PubMed
- Chan YH, et al. 2019. EMBO Mol Med. 11:e10092. PubMed
- LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
- Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
- Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
- Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
- Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
- Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed
- Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
- Campana L, et al. 2018. J Immunol. 200:1169. PubMed
- Green CD et al. 2018. Developmental cell. 46(5):651-667 . PubMed
- Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
- Wang C, et al. 2021. Cell Rep. 37:110021. PubMed
- Mooney J, et al. 2015. Sci Rep. 5: 14603. PubMed
- Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed
- Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
- Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed
- Taube C, et al. 2011. PLoS One. 6:e21799. PubMed
- Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
- Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
- Wessel AW, et al. 2020. Nat Commun. 4.123611111. PubMed
- Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed
- Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
- Kishore M et al. 2017. Immunity. 47(5):875-889 . PubMed
- Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
- Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed
- Ullah I, et al. 2021. Immunity. 54:2143. PubMed
- Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed
- Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed
- Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed
- Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
- Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
- Li Z, et al. 2018. Front Immunol. 9:347. PubMed
- LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
- De Veirman K, et al. 2021. Oncoimmunology. 10:2000699. PubMed
- Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed
- Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
- Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
- Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
- M H, et al. 2016. Sci Rep. 6: 20588. PubMed
- Song P, et al. 2018. Int J Mol Med. 41:935. PubMed
- Yazlovitskaya EM, et al. 2021. J Cell Sci. 134:. PubMed
- Yang R, et al. 2022. J Adv Res. 35:259. PubMed
- Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
- Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
- Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
- Spix B, et al. 2022. Nat Commun. 13:318. PubMed
- Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
- Chitu V, et al. 2020. Cell Reports. 30(9):3004-3019. PubMed
- Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
- Marcandalli J et al. 2019. Cell. 176(6):1420-1431 . PubMed
- Chen Z, et al. 2019. Mol Med Rep. 19:3210. PubMed
- Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
- Wieghofer P, et al. 2021. EMBO J. 40:e105123. PubMed
- Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed
- Li E, et al. 2021. Front Immunol. 12:667177. PubMed
- Glasenapp A, et al. 2021. Circ Res. 129:369. PubMed
- Haase P, et al. 2020. Eur J Immunol. 50:558. PubMed
- Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
- Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed
- Akoolo L, et al. 2021. Cell Microbiol. 23:e13350. PubMed
- Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
- Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
- Eastman AE, et al. 2020. Cell Rep. 31:107804. PubMed
- Reed-Geaghan EG, et al. 2020. J Exp Med. 217:00:00. PubMed
- Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
- Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
- Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
- Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
- Carson W, et al. 2011. PLoS One. 6:e20385. PubMed
- Spevak CC, et al. 2020. Cell Stem Cell. 26(5):755-765. PubMed
- Li H, et al. 2022. iScience. 25:104481. PubMed
- Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed
- Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
- Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed
- Hohsfield LA, et al. 2021. Elife. 10:. PubMed
- RRID
- AB_1732068 (BioLegend Cat. No. 100219) AB_1732057 (BioLegend Cat. No. 100220)
- Structure
- Ig superfamily, CD3/TCR, 20 kD
- Distribution
-
Thymocytes (differentiation dependent), mature T cells, NK-T cells
- Function
- Antigen recognition, TCR signal transduction, T cell activation
- Ligand/Receptor
- Peptide antigen/MHC-complex
- Antigen References
-
1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Davis MM. 1990. Annu. Rev. Biochem. 59:475.
3. Weiss A, et al. 1994. Cell 76:263.
- Gene ID
- 12502 View all products for this Gene ID
- UniProt
- View information about CD3 on UniProt.org
